Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jan;65(1):190-4.
doi: 10.1128/JVI.65.1.190-194.1991.

Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain

Affiliations

Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain

E O Freed et al. J Virol. 1991 Jan.

Abstract

The V3 loop, located near the middle of the surface envelope glycoprotein gp120, is the major neutralizing domain of human immunodeficiency virus type 1 (HIV-1). Although the majority of the V3 loop is highly variable between different strains of HIV-1, a Gly-Pro-Gly-Arg motif at the tip of the loop is highly conserved. To determine whether this region plays a role in fusion mediated by the HIV-1 envelope glycoproteins, we introduced seven single-amino-acid changes in the V3 loop. The mutant envelope glycoproteins were expressed from an HIV-1 envelope expression vector and analyzed for their ability to induce cell fusion in the absence of virus replication. Our results indicated that single-amino-acid changes in the V3 loop were capable of completely abolishing or greatly reducing the ability of the HIV-1 envelope glycoproteins to induce cell fusion, thereby identifying the V3 loop as a fusion domain of HIV-1. Mutations in the highly conserved tip of the loop or in a nonconserved region flanking the highly conserved tip had no effect on envelope glycoprotein synthesis, processing, transport, or binding to the CD4 receptor molecule. Mutation of the putative disulfide bridge-forming Cys at residue 336 blocked gp160 cleavage and CD4 binding.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6768-72 - PubMed
    1. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4 - PubMed
    1. Nature. 1990 Jan 18;343(6255):219 - PubMed
    1. AIDS. 1989 Dec;3(12):777-84 - PubMed
    1. J Virol. 1990 May;64(5):2250-9 - PubMed

Publication types